Tuesday, 13 May 2014

MedChem and CADD-2016

About Conference

OMICS International cordially invites Pharma and Biotech professionals from all over the world to take part in Worldwide Pharma Meeting-WPM at the upcoming 5th International Conference on Medicinal Chemistry and Computer Aided Drug Designing.
Our primary focus is to learn and share knowledge on current Pharma and Biotech research. Leading worldwide scientists, eminent scholars, professors and students gathers under single roof in Phoenix to speak on Medicinal Chemistry and Computer Aided Drug Designing.  MedChem & CADD-2016 International Conference aims in accelerating scientific discoveries and latest innovations in chemistry and drug designing with the application of Nanotechnology (Nanodrug-Chemistry) and Material Sciences (Materialistic Chemistry) in it.
It has been estimated that in the field of medicinal chemistry more than $79 million has spent in research funding since 2008. A complete overview of drug designing process with comparison to conventional approaches of drug discovery has come up with some crucial details, which says that from year 2008 to 2013 the market has grown to $198 billion and in further this rate may increases to $236 Billion from year 2014 to 2019. Special emphasis has given on computational approaches for drug discovery along with salient features and applications of the software’s used in novel research studies.
OMICS International Organises 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientificsocieties and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
For more information, please visit: Medicinal Chemistry Market Analysis

Conference Highlights

  • Novel Drug Design
  • Computer Aided Drug Design-CADD
  • Fluorination in Medicinal Chemistry
  • Nanomedicine & Fullerene Chemistry
  • Advanced Medicinal Chemistry
  • Materialistic Chemistry & Synthetic Chemistry
  • Drug Design and Chemistry: Cancer Studies
  • Neurodegenerative Diseases
  • Drug Discovery and Drug Development
  • Advances in Drug Discovery
  • Hybrid Techniques & Lab-on-a-chip
  • Pharma Market Audit

Special Issues

  •         All accepted abstracts will be published in respective OMICS International Journals.
  •         Abstracts will be provided with Digital Object Identifier by Cross Ref.